ESR1 and breast carcinoma: Luminal ER and PR-positive breast cancer can be further divided into two subtypes based on the proliferation marker Ki-67: luminal A, which exhibits low Ki-67 levels, and luminal B, characterized by high Ki-67 levels [9–11].